How Better Data Fosters Health Equity w/ Kirsten Axelsen
If we want data and clinical trials that meaningfully represent the population of people who take the drug, we’ll need to do more than just issue guides.
In this episode, we interview returning guest Kirsten Axelsen,Senior Advisor for Charles River Associates, about making medicine more accessible to lower income people and creating a more equitable health system with better data.
Join us as we discuss:
The detrimental effects of price controls on early life stages of drug development
Why a price control on one is a price control on all
The deep concerns about health disparity and equity
How…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.